Form 4: Assembly Biosciences Executive Sells Shares to Cover Tax Obligations

Nicole S. White, Chief Manufacturing Officer of Assembly Biosciences, sold 785 shares of common stock on August 2, 2024, to cover tax withholding obligations related to the vesting and settlement of restricted stock units.

Summary

• On August 2, 2024, Nicole S. White, the Chief Manufacturing Officer of Assembly Biosciences, sold 785 shares of the company's common stock.
• The sale was executed at a weighted average price of $14.2325 per share, with individual transactions ranging from $14.08 to $14.39.
• This transaction was conducted to cover tax withholding obligations associated with the vesting and settlement of restricted stock units, as mandated by an administrative rule adopted by the Compensation Committee.
• Following the transaction, White directly owns 12,068 shares of Assembly Biosciences common stock.

Sentiment

Score: 5

Explanation: This is a neutral event. The sale is related to tax obligations and doesn't necessarily reflect the executive's sentiment about the company's future prospects.

Industry Context

This is a routine Form 4 filing, which is common when company executives sell shares, especially to cover tax obligations related to equity compensation. It doesn't necessarily indicate a change in the executive's outlook on the company.

Key Dates